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Abstract 
To report a case of acinic cell carcinoma occurred in the lacrimal gland. A 59-year-old man was 
admitted because of sudden blurring of vision, progressive proptosis of the left eye, and mild 
double vision in left and down directions of the gaze (Hess-Lancaster test). His medical history 
detailed controlled bilateral keratoconus and open angle glaucoma. On examination, the best 
corrected visual acuity decreased from 8/20 till 1/50 in one week. There was a swelling of the 
left upper eyelid. A hard and tender mass was palpated in the superior temporal left orbit. 
Ultrasound scan showed an extraconal solid mass, situated in the superior lateral corner of the 
orbit. Computed tomography and magnetic resonance imaging (MRI) revealed a mass of two 
centimeters in diameter, with round well-defined outline, within the lacrimal gland. We per-
formed an enucleoresection of the mass, via a coronal approach and a lateral orbitotomy by a 
piezosurgical device. The lesion appeared nodular, brownish, measuring about 2 × 1.5 cm. 
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Histopathological findings were consistent with acinic cell carcinoma with a microcystic, focally 
papillary-cystic growth of pattern. Follow-up MRI outcomes led to removal of the residual  
lacrimal gland for suspicion of recurrence. No tumor recurrences where detected at 7-year 
follow-up. © 2019 The Author(s) 
 Published by S. Karger AG, Basel 
Introduction 
Lacrimal pathologies arise from all the structures related to the gland: epithelial tissue, 
lymphoid tissue, nervous and vascular tissue. Inflammatory and lymphoid lesions are two to 
three times more common than epithelial tumors that account for only 20–30% of lesions. The 
normal lacrimal gland is clinically impalpable and is located behind the supero-temporal or-
bital rim, in a hollow of the frontal bone called lacrimal fossa. Space occupying lesions of the 
lacrimal gland and its fossa constitute approximately 5% to 25% of orbital masses upon bi-
opsy [1]. Epithelial tumors usually arise from the orbital lobe of the lacrimal gland and tend 
to spread posteriorly within the orbit, along its lateral margin. However, around 17% of epi-
thelial tumors arise from the palpebral segment and may be clinically visible in the fornix of 
the conjunctiva [2].  
The initial diagnosis is often wrong because these masses could be confused with a het-
erogeneous group of inflammatory lesions or benign neoplasms. The histopathologic classifi-
cation of epithelial lacrimal gland tumors is identical to that used in salivary gland tumors, as 
originally proposed by Foote and Frazell [3]. Rootman et al. in 2009 proposed an histopatho-
logic type classification of lacrimal tumors, dividing the tumors into low and high grade on the 
basis of the World Health Organization classification of salivary gland neoplasm, although 
some histopathologic type have been described only in case report series (Table 1) [4, 5]. In 
order of frequency, the most common epithelial tumors are: benign mixed tumor or pleo-
morphic adenoma, adenoid cystic carcinoma and adenocarcinoma. Other rare variants of car-
cinoma are also seen, such as mucoepidermoid carcinoma and squamous cell carcinoma of the 
lacrimal gland [6–8]. 
In this paper, we focused on clinical management of low grade malignant primary epithe-
lial tumors of the lacrimal gland, in particular on acinic cell carcinoma (AcCC) and we pre-
sented a case report.  
Case Report/Case Presentation 
In January 2012 a 59-year-old man was referred to the ophthalmologist for a sudden blur-
ring of vision and orbital swelling on the left eye; his medical history detailed a bilateral kera-
toconus and open angle glaucoma, well controlled with topical therapy. The best corrected 
visual acuity decreased from 8/20 till 1/50 in one week. A corneal edema in the left eye was 
detected by physical examination and the retina was not detectable. In order to investigate 
the disease, the physician required an orbital ultrasound scan, which showed an extraconal 
solid mass with round well-defined outline, situated in the superior lateral corner of the left 
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orbit. The patient was then admitted to treat this intra-orbital tumor at Cranio-Maxillo-Facial 
Unit, University Hospital of Modena. 
The patient had a proptosis of the left eye at the time of admission into the hospital (Fig. 
1a). There was a swelling of the left upper eyelid. A hard and tender mass was palpated in the 
superior temporal left orbit. The patient complained of mild double vision in left and down 
directions of the gaze, with a pathologic Hess-Lancaster test. The horizontal separation of per-
ceived images by the patient and the worsening of diplopia in left gaze suggested limitation of 
left lateral rectus movement, since double vision is often worse in the field of action of the 
weakened ocular muscle.  
Computed tomography (CT) revealed a mass which was 2 × 2.5 cm in size, well circum-
scribed, of ovoid shape, within the left lacrimal fossa, with a central region hypodense to mus-
cle and homogeneous soft tissue density border (Fig. 1a, e). The tumor displaced medially the 
lateral rectus muscle (Fig. 1c). The mass did not appear well separable from the lacrimal gland 
and a slight scalloping of the greater sphenoid wing was evident (Fig. 1a). MRI showed an oval 
mass in the left lacrimal fossa, about two centimeters in diameter that appeared within normal 
lacrimal gland tissue. Tumor was heterogeneous, with mild and irregular enhancement fol-
lowing administration of contrast medium (gadolinium) (Fig. 1c, d, f–h). Radiologist described 
a solid mass within the lacrimal gland, hypothesizing a pleomorphic adenoma. However, since 
imaging findings were not pathognomonic, we decided to proceed with complete excision of 
the mass, without a diagnostic incisional biopsy. Preoperative CT and MR imaging were con-
sistent with a completely localized disease within the lacrimal gland. To approach this malig-
nancy we chose a coronal approach to get an easy control of the lacrimal fossa and aestheti-
cally and functionally preserve the eyelid and periorbital skin. After general anesthesia and 
local injection of lidocaine and epinephrine (lidocaine and epinephrine 1:200,000), a bicoro-
nal skin incision was made a few millimeters behind the hairline and just anterior to the tragus 
of the left ear, extending approximately to the superior temporal line on the opposite side. The 
scalp flap was developed anteriorly to expose the orbital margin from the superior orbital rim 
to the zygomatic arch; so the facial nerve preservation was achieved [9]. Then, the temporalis 
muscle was dissected subperiosteally and retracted posteriorly to completely expose the lat-
eral orbital rim and the outer surface of the great sphenoid wing. The periorbita was elevated 
from the inner surface of the lateral wall of the orbit. After preplating the lateral orbital rim 
with two titanium microplates, a lateral orbitotomy was performed using a piezoelectric os-
teotome (Piezosurgery® Medical; MT1–10 tip; Mectron Medical Technology, Carasco, Italy), 
because less traumatic for orbital content and to improve osteotomic bone healing [10–12]. 
The former osteotomy was made just above the zygomatic-frontal suture line and the latter 
approximately 1, 5 cm below. The lateral orbital rim was out-fractured with a rongeur, re-
moved and preserved in saline solution. The periorbita was opened, showing a mass of ap-
proximately 2 cm, adherent to the lacrimal gland (Fig. 2a). The lesion was well demarcated 
within the lacrimal gland and enucleoresection was performed. The periorbital fascia was re-
located and the lateral orbital rim was reinserted in its correct anatomic position and fixated 
with previous pre-platted two microplates and screws (Fig. 2b) [13], without the need for a 
bone substitute [14–21]. A drain tube was placed; the muscular fascia, subcutaneous tissue 
and skin suturing is performed without any local flaps [22]; a firm compressive dressing is 
applied for 48 hours and then removed.  
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On gross examination the lesion appeared nodular, brownish, measuring about 2 × 1.5 
cm. Histopathological examination demonstrated a monomorphic epithelial tumor, composed 
of basophilic cells with prominent nucleoli and granular cytoplasm. Microcystic and focal pa-
pillary areas were present (Fig. 3a). Melanin pigment deposition was occasionally revealed 
(Fig. 3b). Immunohistochemistry revealed positivity for cytokeratin 7. Immunohistochemical 
analyses using S-100 protein, p63 (transformation-related protein 63), CD34 (cluster of des-
ignation 34), TTF1 (thyroid transcription factor-1), CD 10 (cluster of designation 10) and mus-
cle actin antibodies were negative. Histopathological findings were consistent with acinic cell 
carcinoma (AcCC) with a microcystic, focally papillary-cystic growth of pattern. The mass ap-
peared well-circumscribed, and did not involve the margins of resection. There was no evi-
dence of vascular nor perineural invasion. Neither mitosis nor necrosis was observed. Prolif-
eration rate was 2–4%, according to MIB-1 (antibody against Ki-67 protein) proliferation in-
dex. According to American Joint Committee on Cancer (AJCC) Eight Edition Staging System 
for lacrimal gland carcinomas, the staging of this AcCC is T1N0M0 [23]. 
The postoperative course was uneventful, exophthalmos and ocular pain slowly subsided. 
Acuity vision improved and the patient was discharged 3 days after the operation. Early post-
operative head CT scan showed complete removal; contrast chest CT scan and ultrasound scan 
of the liver were performed to assess pulmonary or liver metastases, which resulted respec-
tively normal. The patient’s case was debated at our local head & neck cancer multidiscipli-
nary team meeting. Given the low grade malignancy of this tumor and the apparent radical 
excision of the mass, the meeting decided for no other postoperative treatment and to carry 
out a careful follow-up in order to notice any eventual recurrence. MRI at 6 months showed 
an area of solid tissue of about 1.5 cm characterized by a low enhancement in the left lacrimal 
fossa. The patient did not present any clinical signs of disease. Considering the lack of speci-
ficity of MRI in detecting a low grade malignancy recurrence, we decided to perform the com-
plete removal of the residual lacrimal gland under general anesthesia through the previous 
coronal access. Histological examination of the surgical specimen revealed normal lacrimal 
gland and fibrous tissue free from cancer. 
Visual acuity was 8/20 fifteen months after surgery; the keratoconus did not get worse 
and no corneal edema and flare were present in anterior chamber. Intraocular pressure was 
14 mm Hg without changes in topical therapy. The patient did not refer diplopia. Hess-Lan-
caster test showed recovery of extraocular muscles action. The patient is now free from dis-
ease at 7-year follow-up. Hyaluronic acid eye drops (Xailin HA, Visufarma, s.p.a., Rome, Italy) 
were provided in the post-operative period for the left eye, to compensate for the reduced 
lacrimation that would now affect that eye. As time goes by tears from accessory lacrimal 
glands were sufficient to maintain a stable tear layer on the cornea, and artificial tears use 
have come to be not regular. No tumor recurrences where detected at 7-year follow-up. 
Discussion 
AcCC is very rare in lacrimal gland and exceptional in the sinonasal tract [24]. The imaging 
characteristics of lacrimal gland tumors are nonspecific, with most lesions having a generally 
benign appearance, often appearing on CT and on MRI as a pleomorphic adenoma [25]. No 
papers are present in the English literature about positron emission tomography/computed 
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tomography (PET/CT) for AcCC of the lacrimal gland, whereas PET/CT may identify primary 
adenoid cystic carcinoma of the lacrimal gland [26]. 
The initial management of low grade malignant primary epithelial tumors of the lacrimal 
gland is complete surgical resection with tumor-free margins, given the difficulty in preoper-
atively differentiating malignant from benign lesions. Incisional biopsy for diagnosis is often 
avoided because this procedure is occasionally associated with local recurrences [27, 28]. The 
histological examination of surgical specimen remains the only method for a correct diagnosis. 
For small tumors of lacrimal apparatus Skinner et al. (2011) in a large study recommended 
evaluating eye-preserving surgery; adenoid cystic carcinoma was present in nearly half of 
these group of patients, histotype characterized by the worst prognosis between malignant 
neoplasia. Although the mainstay of treatment for malignant lacrimal gland tumors is surgery, 
the option among orbital sparing conservative surgery followed by postoperative radiation 
and orbital exenteration/cranio-facial approaches is debated [29–31]. Major evidences on 
postoperative radiotherapy effectiveness in local control of disease in lacrimal gland malig-
nancies come from adenoid cystic carcinoma cases retrospective analysis [8], and are not ap-
propriate to low grade malignancies. 
Only four other cases of acinic cell carcinoma in the lacrimal gland have been reported in 
patients from 18 to 78 years of age (Table 2, Table 3) [32–35] and one case was present in 
case series of Verdijk et al. [36]. Two of these lesions showed a benign clinical behavior, while 
two proved to be aggressive, characterized by histopathological infiltrative comportment: 
bone involvement, intracranial extensions and local recurrence (Table 2, Table 3). In our case 
the mass was completely situated within the orbital lobe of the gland in the lacrimal fossa, 
without bone erosion. At the time of diagnosis no lymph nodal localization or distant metas-
tasis were detected. Our patient was treated through an eye-sparing surgery that is excision 
of the mass together with a cuff of normal gland tissue around the lesion, followed 6 months 
later by residual gland removal for suspicion of recurrence. Considering the favorable prog-
nostic factor (the malignancy is completely localized within normal lacrimal gland tissue, the 
lack of perineural and vascular invasion, the low mitotic index, the absence of mitosis and ne-
crosis, and the integrity of the cortical bone and the surrounding soft tissue) and the disabling 
complications of more postoperative treatments, nor more therapies had been applied. Ex-
pected survival and freedom of metastasis for this patient is good, according to the state of 
low grade malignancy for AcCC and the staging (≤T2) [31].  
TNM classification for primary carcinomas of the lacrimal gland is significantly changed 
from the AJCC Cancer Staging Manual, 7th Edition staging system. Comparing seventh and 
eighth edition of the AJCC staging system, we can note that the attention for bone involvement 
has gained importance [5, 23]. Broadly speaking, local extent of cancer contribute in deter-
mining appropriate treatment [37], and for carcinoma high T number often relates to more 
extensive surgery. In orbital pathology extensive and demolitive surgery corresponds to exen-
teration orbitae, while more and more authors recommend globe-preserving surgery, based 
on similar survival outcomes to those in patients treated with an orbital exenteration [31]. 
T1 or T2 – a mild score – can indifferently correspond to orbital sparing surgery or orbital 
exenteration in seventh and eighth edition of AJCC Staging Manual, lacrimal gland carcinoma 
staging system (Table 2, Table 3). In clinical practice the following factors determine the sur-
gical extent in lacrimal gland malignancies: infiltrated orbital tissue beyond lacrimal capsule, 
sphenoid bone involvement, intracranial extension, dura involvement suspicion, high grade 
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carcinoma, treatment of recurrence [31, 38, 39]. According to us the correlation between high 
T score and wide surgical excision (exenteration orbitae) is not strong for AcCC (Table 2, Table 
3) and for other low grade carcinomas of the lacrimal gland, in both last two editions of the 
AJCC staging system manual, lacrimal gland carcinoma staging system. However, it is im-
portant to remember that changes undertaken by the authors of the AJCC Cancer Staging Man-
ual, 8th Edition lacrimal gland carcinoma staging system are aimed to determining which fac-
tor—tumor size or periosteal or bone invasion – is the most important factor in defining out-
come for these malignancies [23]. 
In our opinion, considering the limited literature inherent lacrimal gland AcCC, the clinical 
care of low grade malignancy should considerate some aspects. Diffusion of the malignancy 
outside of lacrimal gland, history of recurrences, periosteal involvement, bone erosion, dural 
infiltration, high mitotic index, and presence of perineural and vascular invasion can predict a 
poor outcome: in this situation radical surgery even or without eye-preserving is necessary; 
adjuvant radiation therapy is mandatory or consider neutron therapy, if available. We recom-
mend eye-preserving surgery for a new onset of a localized low grade malignancy of lacrimal 
gland, to be carried out by an entire en bloc removal of the lacrimal gland through a lateral 
orbitotomy for wide exposure in large lesions [39]. A close follow up through MR imaging is 
advisable. However, as the imaging characteristics of AcCC are nonspecific, a suspicion of re-
currence disclosed during imaging follow-up requires a surgical biopsy. More studies for low 
grade malignancies of the lacrimal gland supported by large numbers of patients are needed. 
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Fig. 1. Images of a solid mass (acinic cell carcinoma) within the left lacrimal gland. (a) Axial CT-scan images 
show an oval mass (2 × 2.5 cm) of heterogeneous density associated with the left lacrimal gland. There is 
a modest scalloping of the great wing of the left sphenoid bone. (b) CT-scan in axial view. The interzygo-
matic line was used as a reference for measuring the exophthalmos. 22.14 mm in right eye versus 25.65 
mm in left one. Exophthalmos amounts of 3.51 mm. (c) T1-weighted spin-echo MR imaging of the tumor. 
The contour of the lesion is evident, as well as the separation between the mass and the extraocular muscle, 
the rectus lateralis muscle. (d) T2-weighted turbo spin-echo MR imaging shows an oval well defined mass 
in the superolateral extraocular compartment of the left orbit within lacrimal fossa; it is in contact with 
the postero-superior outline of the ocular globe. (e) coronal CT-scan images show an oval mass of hetero-
geneous density associated with the lacrimal gland. (f) T1-weighted spin-echo coronal MR imaging of the 
tumor. The outline of the lesion is evident; the density of the mass is not homogenous. (g) T1-weighted 
contrast-enhanced fat-suppressed spin-echo MR imaging. The tumor is well limited and presents a mild 
contrast-enhancement. (h) T2-weighted turbo spin-echo MR imaging. The tumor has well-defined borders 
and irregular density in the superolateral extraocular compartment of the left orbit within lacrimal fossa. 
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Fig. 2. Intraoperative views. (a) The left lacrimal fossa was exposed by means of the coronal approach, the 
skeletonization of the temporal fossa and the lateral orbitotomy was performed with piezosurgical scalpel. 
The acinic cell carcinoma appeared as a well circumscribed red-bluish mass within the lacrimal gland. (b) 
The left lateral orbital rim is easily repositioned throughout the pre-platted titanium plates. The oste-
otomic lines are thin and the matching with the orbital rim is accurate because a piezosurgical device was 
used. 
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Fig. 3. (a) Light micrograph. The tumor was composed of basophilic cells with prominent nucleoli and in-
tracytoplasmic fine granules of brownish pigment arranged in a solid and microcystic growth pattern (he-
matoxylin-eosin stain, 200× magnifications). (b) Light micrograph. Melanin pigments occasionally deposit 
in the interstitium (Masson-Fontana stain, 200× magnification). 
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Table 1. Histopathologic type of low grade malignant primary epithelial tumors of the lacrimal gland [23] 
 
 
Carcinoma ex pleomorphic adenoma (see WHO classification for definition)  
Polymorphous low-grade carcinoma 
Mucoepidermoid carcinoma, grades 1 and 2 
Epithelial-myoepithelial carcinoma 
Cystadenocarcinoma and papillary cystadenocarcinoma 
Acinic cell carcinoma 
Basal cell adenocarcinoma 
Mucinous adenocarcinoma 
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Table 2. Clinical history of the reported cases of acinic cell carcinoma of the lacrimal gland in the English 
literature and the present case report 
             
             
Author  
(year  
reported) 
Sex Age at  
the time  
of diag- 
nosis 
Presentation  Imaging  Preoperative incisional 
biopsy and Treatment 
(globe-sparing surgery/ 
orbital exenteration) 
 Pathology and pathology related 
variables 
 AJCC TNM  
      7th  
edition 
8th  
edition 
             
             
De Rosa  
et al.,  
1986  
[32] 
F 59 Painless exophthal-
mos, intraocular  
pressure raising,  
visual acuity reduced; 
Funduscopic 
examination: promi-
nent retinal folds,  
engorgement 
of intraocular veins 
 CT: a large, round cystic mass 
in the right lacrimal fossa 
 No incisional biopsy; 
Globe-sparing surgery 
Temporal orbitotomy 
and total removal of the 
lesion respecting the  
thin capsule; No post- 
operative treatment 
Follow-up did not 
showed neither local  
relapses nor metastases 
 Gross examination: a nodular cap-
sulated mass (30 mm in diameter); 
on cutting it appeared cystic with a 
yellowish, intralesional fluid; Histo-
pathological pattern: mixed pattern 
(solid and acinic with small micro-
cystic spaces); Immunohistology 
not performed; The lesion appeared 
completely encapsulated; Some 
rests of the lacrimal gland could be 
identified; Neither perineural nor 
vascular infiltration was observed 
 pT2N0M0 pT2aN0M0 
                          Rosen- 
baum  
et al.,  
1995  
[33] 
F 18 Previous surgery and 
radiotherapy for  
“adenocarcinoma of 
the lacrimal gland” in 
the same site (1985) 
For 2 years marked 
proptosis and inferior 
displacement of the 
right globe that 
showed limited motil-
ity; A prominent  
superolateral right  
orbital mass was easily 
palpable; Visual acuity 
reduced 
 CT: massive retrobulbar and 
extraconal orbital tumor 
demonstrating mixed cystic 
and solid components;  
No intracranial extension was 
noted; Present associated 
sclerosis of the greater  
sphenoid wing and erosive 
changes of the superior,  
posterior, and lateral orbital 
walls 
 In 1985: a right lateral 
orbitotomy was per-
formed for "adenocarci-
noma of the lacrimal 
gland;" Four months 
later, she received cobalt 
60 (45 Gy) external 
beam irradiation to the 
right orbit for tumor  
recurrence 
In 1988: incisional  
biopsy revealed a diag-
nosis of "poorly differen-
tiated adenocarcinoma;" 
One month later an  
exenteration of the right 
orbit was performed 
 1988: Gross examination of the  
exenteration specimen: a firm,  
multinodular mass; measuring 
37×28×31 mm; on cutting the  
tumor appeared multinodular, 
brown-tan, and showed a large 
cystic cavity containing friable 
brown material; No normal lacrimal 
gland tissue was grossly identified; 
The tumor deformed the globe  
superiorly and was adherent to the 
temporal portions of the upper and 
lower lids; Histopathological  
pattern: predominantly microcystic 
Immunohistology performed;  
No bone involvement was  
described 
 rpT2N0M0 rpT2aN0M0 
                          Jang  
et al.,  
2001  
[34] 
M 51 Intermittent swelling 
of the temporal upper 
eyelid for 2 years; 
Painful proptosis and 
headache for two 
months 
Reduced visual acuity; 
A hard and tender 
mass was palpated in 
the superior-temporal 
orbit 
 CT: a 33 x 23 mm mass with 
homogeneous enhancement 
in the superior temporal  
orbit; The mass displaced the 
eye inferiorly and eroded the 
orbital roof and wall; T2-
weighted MRI showed an  
intermediate signal density; 
Enhancement of the lesion  
after administration of  
gadolinium contrast 
Intracranial extension was  
evident on the coronal scan; 
No evidence for distant  
metastasis 
 Incisional biopsy:  
acinic cell carcinoma 
Exenteration of the right 
orbit with excision of 
dura and sphenoid bone 
and removal of the intra-
cranial mass through a 
transcranial approach; 
No post-operative  
treatment 
No recurrence after 2 ½ 
years follow-up  
 Gross examination: a yellowish-
gray, solid, firm mass, measuring  
35 x 25 mm was in the retrobulbar 
area; The mass had an infiltrative 
border not involving the margins; 
Histopathological pattern: solid and 
microcystic pattern 
Immunohistology performed;  
Perineural invasion was no evident 
The normal palpebral segment of 
the lacrimal gland was seen in the 
adjacent eyelid 
Dura and sphenoid bone were  
involved by the tumor 
 pT4bN0M0 pT2cN0M0 
 
 
The AJCC TNM staging score of both the seventh and eighth editions was reported [5, 23]. Tumor size, periosteal and bone invasion are separately staged in the AJCC Cancer Staging Manual, 
8th Edition lacrimal gland carcinoma staging, for understanding how these factors correlate with survival for these malignancies. No stage groupings are currently recommended for 
lacrimal gland carcinomas. The authors of lacrimal gland carcinoma staging in AJCC Cancer Staging Manual, 8th Edition pointed out the frailty of this classification due to the lack of large 
studies [23]. In the five case reports of AcCC here discussed we can compare the staging score among seventh and eighth edition of AJCC staging system, and some observations can be 
made. A downgrading in T staging can be noticed in the case described by Jang [34] from T4b to T2c, respectively in seventh and eighth edition of the AJCC staging system. No significant 
changes in staging are detectable comparing the seventh and eighth edition of the AJCC staging system in reviewing the other 3 cases of AcCC of the literature and the case report here 
described. Focusing on surgical treatment for AcCC of the lacrimal gland, we can note that the tumor extent in the case reported by Rosenbaum [33] required an orbital exenteration 
because of globe and eyelid involvement. Orbital exenteration is related to high morbidity, but according to the seventh and eighth edition of the AJCC staging system, T number (T2) in 
Rosenbaum’s case [33] is analogue to T scoring in De Rosa’s case [32], in Bannister and Lawson’s case [35], and in the case here presented, in all of which orbital sparing surgery was 
successfully used and not orbital exenteration. In conclusion, the correlation between high T score and wide surgical excision (exenteration orbitae) is not strong for AcCC and for other low 
grade carcinomas of the lacrimal gland, in both last two editions of the AJCC staging system manual lacrimal gland carcinoma staging system.  
 
 
 
 
 Case Rep Oncol 2019;12:777–790 
DOI: 10.1159/000503557 © 2019 The Author(s). Published by S. Karger AG, Basel 
www.karger.com/cro 
Anesi et al.: Clinical Management of Acinic Cell Carcinoma of the Lacrimal Gland 
 
 
 
 
790 
Table 3. Clinical history of the reported cases of acinic cell carcinoma of the lacrimal gland in the English 
literature and the present case report (continued) 
             
             
Author  
(year  
reported) 
Sex Age at  
the time  
of diag- 
nosis 
Presentation  Imaging  Preoperative incisional 
biopsy and Treatment 
(globe-sparing surgery/ 
orbital exenteration) 
 Pathology and pathology related 
variables 
 AJCC TNM  
      7th edition 8th edition 
             
             
Bannister  
and  
Lawson, 
2014  
[35] 
F 78 A 12-month history of 
a mass over the right 
eye 
No pain or change in 
periocular sensation; 
Normal visual acuity 
 CT: Supraorbital mass 
arising from the palpebral 
lobe of the lacrimal gland, 
without orbital erosion 
 No incisional biopsy; 
Globe-sparing surgery; 
Orbitotomy and entire 
lacrimal gland removal 
No post-operative treat-
ment; No recurrence 
 Histopathological pattern: papil-
lary-cystic variant AcCC; The lesion 
appeared completely within the 
lacrimal gland; Some rests of the 
lacrimal gland could be identified; 
No immunohistochemical analysis; 
No tumor size was specified  
(comment by the author, Anesi A.) 
 No tumor size 
was specified 
in the paper; 
The mass did 
not overtake 
the normal 
gland  
boundaries 
So we can 
roughly infer 
that the mass 
did not exceed 
20 mm and 
staging score 
could be 
pT1N0M0 
(comment by 
the author, 
Anesi A.) 
No tumor size 
was specified 
in the paper; 
The mass did 
not overtake 
the normal 
gland  
boundaries 
So we can 
roughly infer 
that the mass 
did not exceed 
20 mm and 
staging score 
could be 
pT1aN0M0 
(comment by 
the author, 
Anesi A.) 
                          Anesi  
et al.,  
2019 
M 59 Sudden blurring of  
vision and supraor-
bital swelling on the 
left eye; Visual acuity 
reduced from 8/20 to 
1/50 in one week 
The patient had a 
proptosis of the left 
eye; A hard and  
tender mass was pal-
pated in the superior 
temporal left orbit; 
The patient  
complained of mild 
double vision in left 
and down directions 
of the gaze, with a 
pathologic Hess- 
Lancaster test 
 CT: a 20×25 mm mas; 
well circumscribed, of 
ovoid shape, within the 
left lacrimal fossa; The  
tumor displaced medially 
the lateral rectus muscle; 
The mass did not appear 
well separable from the 
lacrimal gland and a 
slight scalloping of  
the great wing of the 
sphenoid was evident 
MR: an oval mass in the 
left lacrimal fossa, about  
2 cm in diameter within 
the lacrimal gland; Tumor 
was heterogeneous, with 
mild and irregular en-
hancement following ad-
ministration of contrast 
medium (gadolinium) 
 No incisional biopsy; 
Globe-sparing surgery; 
Coronal approach, lateral 
orbitotomy and entire 
lacrimal gland removal 
respecting the thin  
capsule 
No post-operative  
treatment; No recur-
rence after 7 years 
 Gross examination: nodular and 
brownish lesion, measuring about 
20×15 mm; Histopathological  
examination: monomorphic epithe-
lial tumor, composed of basophilic 
cells; Histopathological pattern: mi-
crocystic and focal papillary AcCC 
Melanin pigment deposition was 
occasionally revealed (Fig. 3b) 
Immunohistochemistry performed 
The mass appeared well-circum-
scribe, without involvement of the 
resection margins; a non-pathologi-
cal portion of the lacrimal gland 
was identified (Fig. 3a); No evi-
dence of vascular nor perineural 
invasion; Neither mitosis nor  
necrosis were observed 
Proliferation rate was 2–4 percent 
according to MIB-1 proliferation  
index 
 pT1N0M0 pT1aN0M0 
 
 
The AJCC TNM staging score of both the seventh and eighth editions was reported [5, 23]. Tumor size, periosteal and bone invasion are separately staged in the AJCC Cancer Staging Manual, 
8th Edition lacrimal gland carcinoma staging, for understanding how these factors correlate with survival for these malignancies. No stage groupings are currently recommended for 
lacrimal gland carcinomas. The authors of lacrimal gland carcinoma staging in AJCC Cancer Staging Manual, 8th Edition pointed out the frailty of this classification due to the lack of large 
studies [23]. In the five case reports of AcCC here discussed we can compare the staging score among seventh and eighth edition of AJCC staging system, and some observations can be 
made. A downgrading in T staging can be noticed in the case described by Jang [34] from T4b to T2c, respectively in seventh and eighth edition of the AJCC staging system. No significant 
changes in staging are detectable comparing the seventh and eighth edition of the AJCC staging system in reviewing the other 3 cases of AcCC of the literature and the case report here 
described. Focusing on surgical treatment for AcCC of the lacrimal gland, we can note that the tumor extent in the case reported by Rosenbaum [33] required an orbital exenteration 
because of globe and eyelid involvement. Orbital exenteration is related to high morbidity, but according to the seventh and eighth edition of the AJCC staging system, T number (T2) in 
Rosenbaum’s case [33] is analogue to T scoring in De Rosa’s case [32], in Bannister and Lawson’s case [35], and in the case here presented, in all of which orbital sparing surgery was 
successfully used and not orbital exenteration. In conclusion, the correlation between high T score and wide surgical excision (exenteration orbitae) is not strong for AcCC and for other low 
grade carcinomas of the lacrimal gland, in both last two editions of the AJCC staging system manual lacrimal gland carcinoma staging system.  
 
 
 
 
 
